IndustryPayments
Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

ROBERT M CONRY

Allopathic & Osteopathic Physicians Internal Medicine Hematology & Oncology

NPI
1548203235
CMS profile
341856
Location
BIRMINGHAM, AL

General Payments · PY2018–2024

$189,339.28

  • Reported across 314 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$1,999.01

64 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

Related groups: Hematology & Oncology AL All categories

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Long term medical supply or device loan $1,065.44 12
Food and Beverage $813.57 50
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $120.00 2

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
NOVARTIS PHARMACEUTICALS CORPORATION $1,281.88 32
PFIZER INC. $217.86 8
Merck Sharp & Dohme Corporation $177.31 8
ABBVIE INC. $83.28 4
Gilead Sciences, Inc. $44.24 2
E.R. Squibb & Sons, L.L.C. $36.48 2
Acerta Pharma LLC $32.96 2
ARRAY BIOPHARMA INC $32.60 2
Daiichi Sankyo Inc. $29.08 1
Takeda Pharmaceuticals U.S.A., Inc. $25.61 1
Janssen Biotech, Inc. $20.82 1
EISAI INC. $16.89 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $48,499.69 58
PY2019 $130,575.43 103
PY2020 $4,475.14 3
PY2021 $877.20 3
PY2022 $1,955.17 45
PY2023 $957.64 38
PY2024 $1,999.01 64

Payment records · PY2024 (64)

Sorted by paying entity, then date · as published by CMS

Program year 2024 201820192020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
ABBVIE INC. $18.86 02/16/2024 Food and Beverage Undisputed 01/23/2026 1103497978 CMS
ABBVIE INC. $29.68 03/27/2024 Food and Beverage Undisputed 01/23/2026 1103497980 CMS
ABBVIE INC. $16.14 06/08/2024 Food and Beverage Undisputed 01/23/2026 1103497982 CMS
ABBVIE INC. $18.60 08/28/2024 Food and Beverage Undisputed 01/23/2026 1103497984 CMS
ARRAY BIOPHARMA INC $11.68 02/02/2024 Food and Beverage Undisputed 01/23/2026 1131442323 CMS
ARRAY BIOPHARMA INC $20.92 06/28/2024 Food and Beverage Undisputed 01/23/2026 1131813026 CMS
AstraZeneca Pharmaceuticals LP $17.20 05/02/2024 Food and Beverage Undisputed 01/23/2026 1104741105 CMS
AstraZeneca Pharmaceuticals LP $15.76 07/25/2024 Food and Beverage Undisputed 01/23/2026 1105755777 CMS
Daiichi Sankyo Inc. $29.08 11/06/2024 Food and Beverage Undisputed 01/23/2026 1089410680 CMS
E.R. Squibb & Sons, L.L.C. $23.15 06/19/2024 Food and Beverage Undisputed 01/23/2026 1101552183 CMS
E.R. Squibb & Sons, L.L.C. $13.33 09/12/2024 Food and Beverage Undisputed 01/23/2026 1101552215 CMS
Eisai Inc. $16.89 01/04/2024 Food and Beverage Undisputed 01/23/2026 1110776757 CMS
Gilead Sciences, Inc. $16.98 02/07/2024 Food and Beverage Undisputed 01/23/2026 1133797827 CMS
Gilead Sciences, Inc. $27.26 06/21/2024 Food and Beverage Undisputed 01/23/2026 1133797829 CMS
Janssen Biotech, Inc. $20.82 07/19/2024 Food and Beverage Undisputed 01/23/2026 1078254243 CMS
Merck Sharp & Dohme LLC $24.44 01/31/2024 Food and Beverage Undisputed 01/23/2026 1141792894 CMS
Merck Sharp & Dohme LLC $24.49 04/11/2024 Food and Beverage Undisputed 01/23/2026 1141792892 CMS
Merck Sharp & Dohme LLC $23.45 05/02/2024 Food and Beverage Undisputed 01/23/2026 1141953005 CMS
Merck Sharp & Dohme LLC $29.35 05/29/2024 Food and Beverage Undisputed 01/23/2026 1141792898 CMS
Merck Sharp & Dohme LLC $23.93 07/17/2024 Food and Beverage Undisputed 01/23/2026 1141792890 CMS
Merck Sharp & Dohme LLC $20.79 07/26/2024 Food and Beverage Undisputed 01/23/2026 1141792896 CMS
Merck Sharp & Dohme LLC $9.63 11/13/2024 Food and Beverage Undisputed 01/23/2026 1141792888 CMS
Merck Sharp & Dohme LLC $21.23 11/14/2024 Food and Beverage Undisputed 01/23/2026 1141899062 CMS
Novartis Pharmaceuticals Corporation $99.70 01/18/2024 Long term medical supply or device loan Undisputed 01/23/2026 1086619531 CMS
Novartis Pharmaceuticals Corporation $99.70 02/16/2024 Long term medical supply or device loan Undisputed 01/23/2026 1086619533 CMS
Novartis Pharmaceuticals Corporation $10.98 02/29/2024 Food and Beverage Undisputed 01/23/2026 1086619491 CMS
Novartis Pharmaceuticals Corporation $18.31 03/07/2024 Food and Beverage Undisputed 01/23/2026 1086619489 CMS
Novartis Pharmaceuticals Corporation $99.70 03/15/2024 Long term medical supply or device loan Undisputed 01/23/2026 1086619535 CMS
Novartis Pharmaceuticals Corporation $99.70 04/18/2024 Long term medical supply or device loan Undisputed 01/23/2026 1086619537 CMS
Novartis Pharmaceuticals Corporation $1.30 04/25/2024 Food and Beverage Undisputed 01/23/2026 1086619497 CMS
Novartis Pharmaceuticals Corporation $12.24 04/25/2024 Food and Beverage Undisputed 01/23/2026 1086619499 CMS
Novartis Pharmaceuticals Corporation $1.32 04/29/2024 Food and Beverage Undisputed 01/23/2026 1086619495 CMS
Novartis Pharmaceuticals Corporation $4.63 05/08/2024 Food and Beverage Undisputed 01/23/2026 1086619493 CMS
Novartis Pharmaceuticals Corporation $83.33 05/16/2024 Long term medical supply or device loan Undisputed 01/23/2026 1086619539 CMS
Novartis Pharmaceuticals Corporation $12.24 05/23/2024 Food and Beverage Undisputed 01/23/2026 1086619501 CMS
Novartis Pharmaceuticals Corporation $1.90 05/23/2024 Food and Beverage Undisputed 01/23/2026 1086619503 CMS
Novartis Pharmaceuticals Corporation $16.70 06/04/2024 Food and Beverage Undisputed 01/23/2026 1086619511 CMS
Novartis Pharmaceuticals Corporation $26.50 06/06/2024 Food and Beverage Undisputed 01/23/2026 1086619505 CMS
Novartis Pharmaceuticals Corporation $83.33 06/13/2024 Long term medical supply or device loan Undisputed 01/23/2026 1086619541 CMS
Novartis Pharmaceuticals Corporation $19.06 06/27/2024 Food and Beverage Undisputed 01/23/2026 1086619507 CMS
Novartis Pharmaceuticals Corporation $0.44 06/27/2024 Food and Beverage Undisputed 01/23/2026 1086619509 CMS
Novartis Pharmaceuticals Corporation $83.33 07/15/2024 Long term medical supply or device loan Undisputed 01/23/2026 1086619543 CMS
Novartis Pharmaceuticals Corporation $2.29 07/23/2024 Food and Beverage Undisputed 01/23/2026 1086619517 CMS
Novartis Pharmaceuticals Corporation $3.60 07/23/2024 Food and Beverage Undisputed 01/23/2026 1086619521 CMS
Novartis Pharmaceuticals Corporation $18.33 08/01/2024 Food and Beverage Undisputed 01/23/2026 1086619513 CMS
Novartis Pharmaceuticals Corporation $83.33 08/23/2024 Long term medical supply or device loan Undisputed 01/23/2026 1086619527 CMS
Novartis Pharmaceuticals Corporation $0.37 09/04/2024 Food and Beverage Undisputed 01/23/2026 1086619519 CMS
Novartis Pharmaceuticals Corporation $13.40 09/04/2024 Food and Beverage Undisputed 01/23/2026 1086619523 CMS
Novartis Pharmaceuticals Corporation $83.33 09/27/2024 Long term medical supply or device loan Undisputed 01/23/2026 1086619529 CMS
Novartis Pharmaceuticals Corporation $7.67 10/07/2024 Food and Beverage Undisputed 01/23/2026 1086619545 CMS
Novartis Pharmaceuticals Corporation $83.33 10/17/2024 Long term medical supply or device loan Undisputed 01/23/2026 1086619549 CMS
Novartis Pharmaceuticals Corporation $83.33 11/14/2024 Long term medical supply or device loan Undisputed 01/23/2026 1086619547 CMS
Novartis Pharmaceuticals Corporation $83.33 12/10/2024 Long term medical supply or device loan Undisputed 01/23/2026 1086619553 CMS
Novartis Pharmaceuticals Corporation $28.72 12/12/2024 Food and Beverage Undisputed 01/23/2026 1086619557 CMS
Novartis Pharmaceuticals Corporation $16.44 12/18/2024 Food and Beverage Undisputed 01/23/2026 1086619555 CMS
PFIZER INC. $11.57 01/19/2024 Food and Beverage Undisputed 01/23/2026 1131442988 CMS
PFIZER INC. $21.86 01/24/2024 Food and Beverage Undisputed 01/23/2026 1130971022 CMS
PFIZER INC. $29.12 01/26/2024 Food and Beverage Undisputed 01/23/2026 1131290062 CMS
PFIZER INC. $18.99 02/15/2024 Food and Beverage Undisputed 01/23/2026 1131055182 CMS
PFIZER INC. $8.43 03/02/2024 Food and Beverage Undisputed 01/23/2026 1131442327 CMS
PFIZER INC. $60.00 05/03/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 1131442161 CMS
PFIZER INC. $60.00 05/03/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 1131442165 CMS
PFIZER INC. $7.89 05/10/2024 Food and Beverage Undisputed 01/23/2026 1131442331 CMS
Takeda Pharmaceuticals U.S.A., Inc. $25.61 08/21/2024 Food and Beverage Undisputed 01/23/2026 1144955653 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.